Skip to main content

Table 2 Comparisons on SF-36, SDS and SAS scores at baseline

From: Effects of G.H.3. On mental symptoms and health-related quality of life among older adults: results of a three-month follow-Up study in Shanghai, China

Domain

Average scores (\( \overline{X}\pm S \))

t

p-value

G.H.3. (n = 48)

Placebo (n = 50)

PF

69.27 ± 26.62

73.10 ± 27.14

−0.705

0.483

RP

41.67 ± 42.32

46.50 ± 41.04

−0.574

0.567

BP

70.42 ± 14.14

72.20 ± 15.82

−0.588

0.558

GH

42.71 ± 19.16

43.20 ± 18.32

−0.130

0.897

VT

56.46 ± 22.14

57.30 ± 20.21

−0.197

0.845

SF

66.41 ± 24.48

69.00 ± 21.91

−0.553

0.581

RE

45.14 ± 39.79

51.33 ± 38.81

−0.780

0.437

MH

57.58 ± 21.26

58.32 ± 19.23

−0.180

0.857

HT

36.98 ± 23.06

35.50 ± 17.56

0.358

0.721

PCS

40.61 ± 13.52

42.11 ± 14.57

−0.525

0.600

MCS

35.02 ± 17.93

36.14 ± 17.02

−0.318

0.751

SDS

54.97 ± 12.27

53.03 ± 11.16

0.823

0.412

SAS

48.88 ± 11.86

46.00 ± 10.22

1.289

0.200